1-3 of 3
Ruozhen Hu
Close
Sort by
Journal Articles

miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

Jared A. Wallace, Dominique A. Kagele, Anna M. Eiring, Carissa N. Kim, Ruozhen Hu, Marah C. Runtsch, Margaret Alexander, Thomas B. Huffaker, Soh-Hyun Lee, Ami B. Patel, Timothy L. Mosbruger, Warren P. Voth, Dinesh S. Rao, Rodney R. Miles, June L. Round, Michael W. Deininger, Ryan M. O’Connell
Journal: Blood
Blood (2017) 129 (23): 3074–3086.
https://doi.org/10.1182/blood-2016-09-740209
Published: 2017
Journal Articles

MiR-155 Promotes FLT3-ITD-Induced Myeloproliferative Disease through Inhibition of Interferon Signaling

Jared Wallace, Dominique Kagele, Ruozhen Hu, Marah Runtsch, Margaret Alexander, Thomas Huffaker, Timothy Mosbruger, Dinesh S. Rao, MD PhD, Rodney R. Miles, MD PhD, June Round, PhD, Ryan M. O'Connell, PhD
Journal: Blood
Blood (2016) 128 (22): 2853.
https://doi.org/10.1182/blood.V128.22.2853.2853
Published: 2016
Journal Articles

Genome-Wide Crispr-Cas9 Screen Identifies Functionally Relevant Micro-RNAs in FLT3-ITD+ AML

Jared Wallace, Dominique Kagele, Ruozhen Hu, Marah Runtsch, Margaret Alexander, Thomas Huffaker, Timothy Mosbruger, Timothy Dahlem, W. Zac Stephens, Dinesh S. Rao, MDPhD, Rodney R. Miles, MD PhD, June Round, PhD, Ryan M. O'Connell, PhD
Journal: Blood
Blood (2015) 126 (23): 3823.
https://doi.org/10.1182/blood.V126.23.3823.3823
Published: 2015